Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


Relationships between serum nivolumab and peripheral blood lymphocyte, serum IgG, or cachexia stage in cancer patients

  • At: PSWC2020 (2020)
  • Type: Poster
  • By: ABE, Kazuki (Hamamatsu University School of Medicine, Department of Hospital Pharmacy, Japan)
  • Co-author(s): Kazuki Abe: Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Kaito Shibata: Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Takafumi Naito: Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Masato Karayama: Department of Clinical Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Atsushi Otsuka: Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Masato Maekawa: Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Yasuhide Yamada: Department of Clinical Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Hideaki Miyake: Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Takafumi Suda: Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Junichi Kawakami: Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan
  • Abstract:

    Background

    Cancer patients have a large variation in serum nivolumab and the variability is partially associated with clinical responses. In cancer patients, endocytotic degradation in lymphocyte, immunoglobulin G (IgG) recycling, and cancer progression are potentially responsible for the variation in nivolumab pharmacokinetics.

    Purpose

    This study

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses